Skip to main content
Premium Trial:

Request an Annual Quote

IDT Acquires Oligo Synthesis Firm ValueGene

NEW YORK (GenomeWeb) – Integrated DNA Technologies announced it has acquired San Diego-based oligonucleotide synthesis firm ValueGene.

ValueGene offers custom synthetic DNA and RNA oligos as well as polyacrylamide gel electrophoresis and high-performance liquid chromatography purification and modification services.

Financial and other terms of the deal were not disclosed.

"ValueGene is well known in San Diego and Los Angeles," Dan Dernbach, IDT's general manager of West Coast operations, said in a statement. "We welcome the opportunity to serve ValueGene's customers and provide them the benefit of our portfolio of reagents for genomics research to support their important discoveries."

Coralville, Iowa-based IDT offers a range of synthetic nucleic acids for molecular biology. The deal is the latest acquisition for the firm and the first since December 2015, when the firm bought the oligonucleotide business of Singapore's AITbiotech. Recently, the firm acquired rights to sell CRISPR/Cas9 reagents in a non-exclusive deal with Caribou Biosciences.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.